-
1
-
-
47149089693
-
Combination of simvastatin with berberine improves the lipid-lowering efficacy
-
Aug
-
Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism. 2008 Aug;57(8):1029-37.
-
(2008)
Metabolism
, vol.57
, Issue.8
, pp. 1029-1037
-
-
Kong, W.J.1
Wei, J.2
Zuo, Z.Y.3
Wang, Y.M.4
Song, D.Q.5
You, X.F.6
Zhao, L.X.7
Pan, H.N.8
Jiang, J.D.9
-
2
-
-
47249158048
-
Traditional chinese medicine in treatment of metabolic syndrome
-
June
-
Yin J, Zhang H, Ye J (June 2008). "Traditional chinese medicine in treatment of metabolic syndrome". Endocrine, Metabolic & Immune Disorders Drug Targets 8 (2): 99-111.
-
(2008)
Endocrine, Metabolic & Immune Disorders Drug Targets
, vol.8
, Issue.2
, pp. 99-111
-
-
Yin, J.1
Zhang, H.2
Ye, J.3
-
3
-
-
84890900990
-
Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
-
Jan
-
Zhou Y, Cao S, Wang Y, Xu P, Yan J, Bin W, Qiu F, Kang N. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells. Fitoterapia. 2014 Jan: 92:230-7.
-
(2014)
Fitoterapia
, vol.92
, pp. 230-237
-
-
Zhou, Y.1
Cao, S.2
Wang, Y.3
Xu, P.4
Yan, J.5
Bin, W.6
Qiu, F.7
Kang, N.8
-
4
-
-
84866495078
-
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
-
Sep 22
-
Pisciotta L, Bellocchio A, Bertolini S. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis. 2012 Sep 22;11:123.
-
(2012)
Lipids Health Dis
, vol.11
, pp. 123
-
-
Pisciotta, L.1
Bellocchio, A.2
Bertolini, S.3
-
5
-
-
71749102883
-
"Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor"
-
November
-
Wang, Yan-Xiang; Wang, Yu-Ping; Zhang, Hao; Kong, Wei-Jia; Li, Ying-Hong; Liu, Fei; Gao, Rong-Mei; Liu, Ting et al. (November 2009). "Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor". Bioorganic & Medicinal Chemistry Letters 19 (21): 6004-8.
-
(2009)
Bioorganic & Medicinal Chemistry Letters
, vol.19
, Issue.21
, pp. 6004-6008
-
-
Wang, Y.-X.1
Wang, Y.-P.2
Zhang, H.3
Kong, W.-J.4
Li, Y.-H.5
Liu, F.6
Gao, R.-M.7
Liu, T.8
-
6
-
-
47149089693
-
Combination of simvastatin with berberine improves the lipid-lowering efficacy
-
Aug
-
Kong WJ et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism. 2008 Aug;57(8):1029-37
-
(2008)
Metabolism
, vol.57
, Issue.8
, pp. 1029-1037
-
-
Kong, W.J.1
-
7
-
-
84893982496
-
Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with, Armolipid Plus
-
Jan-Feb
-
Ruscica M et al. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus. J Clin Lipidol. 2014 Jan-Feb;8(1):61-8
-
(2014)
J Clin Lipidol
, vol.8
, Issue.1
, pp. 61-68
-
-
Ruscica, M.1
-
8
-
-
84860585995
-
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients
-
Dec
-
Marazzi G et al. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011 Dec;28(12):1105-13.
-
(2011)
Adv Ther
, vol.28
, Issue.12
, pp. 1105-1113
-
-
Marazzi, G.1
-
9
-
-
0035843962
-
Structural mechanism for statin inhibition of
-
May 11
-
Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001 May 11;292(5519):1160-4
-
(2001)
HMG-CoA reductase. Science
, vol.292
, Issue.5519
, pp. 1160-1164
-
-
Istvan, E.S.1
Deisenhofer, J.2
-
10
-
-
21244465525
-
Cholesterol and plant sterol absorption: Recent insights
-
Jul 4
-
Von Bergmann K, Sudhop T, Lütjohann D. Cholesterol and plant sterol absorption: recent insights. Am J Cardiol. 2005 Jul 4;96(1A):10D-14D.
-
(2005)
Am J Cardiol
, vol.96
, Issue.1 A
, pp. 10D-14D
-
-
Von Bergmann, K.1
Sudhop, T.2
Lütjohann, D.3
-
11
-
-
78751647742
-
"Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats"
-
March
-
Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L (March 2010). "Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats". Metabolism: Clinical and Experimental 60 (2): 298-305.
-
(2010)
Metabolism: Clinical and Experimental
, vol.60
, Issue.2
, pp. 298-305
-
-
Wang, Y.1
Campbell, T.2
Perry, B.3
Beaurepaire, C.4
Qin, L.5
-
12
-
-
70349157209
-
"Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high fat diet and streptozotocin"
-
August
-
Wang C, Li J, Lv X et al. (August 2009). "Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high fat diet and streptozotocin". European Journal of Pharmacology 620 (1-3): 131-7.
-
(2009)
European Journal of Pharmacology
, vol.620
, Issue.1-3
, pp. 131-137
-
-
Wang, C.1
Li, J.2
Lv, X.3
-
13
-
-
74049139484
-
"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression"
-
September
-
Zhang H, Wei J, Xue R et al. (September 2009). "Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression". Metabolism: Clinical and Experimental 59 (2): 285-92.
-
(2009)
Metabolism: Clinical and Experimental
, vol.59
, Issue.2
, pp. 285-292
-
-
Zhang, H.1
Wei, J.2
Xue, R.3
-
14
-
-
47549100864
-
"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine"
-
July
-
Zhang Y, Li X, Zou D et al. (July 2008). "Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine". The Journal of Clinical Endocrinology and Metabolism 93 (7): 2559-65.
-
(2008)
The Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.7
, pp. 2559-2565
-
-
Zhang, Y.1
Li, X.2
Zou, D.3
-
15
-
-
84884547491
-
Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
-
Oct
-
Pérez-Rubio KG et al. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013 Oct;11(5):366-9.
-
(2013)
Metab Syndr Relat Disord
, vol.11
, Issue.5
, pp. 366-369
-
-
Pérez-Rubio, K.G.1
-
16
-
-
42949145899
-
"Efficacy of berberine in patients with type 2 diabetes mellitus"
-
May
-
Yin J, Xing H, Ye J (May 2008). "Efficacy of berberine in patients with type 2 diabetes mellitus". Metabolism: Clinical and Experimental 57 (5): 712-7.
-
(2008)
Metabolism: Clinical and Experimental
, vol.57
, Issue.5
, pp. 712-717
-
-
Yin, J.1
Xing, H.2
Ye, J.3
-
17
-
-
77955656527
-
"The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells"
-
November
-
Wu LY, Ma ZM, Fan XL et al. (November 2009). "The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells". Cell Stress & Chaperones 15 (4): 387-94.
-
(2009)
Cell Stress & Chaperones
, vol.15
, Issue.4
, pp. 387-394
-
-
Wu, L.Y.1
Ma, Z.M.2
Fan, X.L.3
-
18
-
-
38349006242
-
"Berberine improves glucose metabolism through induction of glycolysis"
-
January
-
Yin J, Gao Z, Liu D, Liu Z, Ye J (January 2008). "Berberine improves glucose metabolism through induction of glycolysis". American Journal of Physiology. Endocrinology and Metabolism 294 (1): E148-56.
-
(2008)
American Journal of Physiology. Endocrinology and Metabolism
, vol.294
, Issue.1
, pp. E148-E156
-
-
Yin, J.1
Gao, Z.2
Liu, D.3
Liu, Z.4
Ye, J.5
-
19
-
-
57049090579
-
"Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression"
-
January
-
Kong WJ, Zhang H, Song DQ et al. (January 2009). "Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression". Metabolism 58 (1): 109-19.
-
(2009)
Metabolism
, vol.58
, Issue.1
, pp. 109-119
-
-
Kong, W.J.1
Zhang, H.2
Song, D.Q.3
-
20
-
-
82955235212
-
Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
-
December
-
Lou T et al. "Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes." Inflammation. December 2011, Volume 34, Issue 6, pp 659-667
-
(2011)
Inflammation
, vol.34
, Issue.6
, pp. 659-667
-
-
Lou, T.1
-
21
-
-
74749103942
-
"Berberine Modulates Insulin Signaling Transduction in Insulin-resistant Cells"
-
December
-
Liu LZ, Cheung SC, Lan LL et al. (December 2009). "Berberine Modulates Insulin Signaling Transduction in Insulin-resistant Cells". Molecular and Cellular Endocrinology 317 (1-2): 148-53.
-
(2009)
Molecular and Cellular Endocrinology
, vol.317
, Issue.1-2
, pp. 148-153
-
-
Liu, L.Z.1
Cheung, S.C.2
Lan, L.L.3
-
22
-
-
59849110456
-
"Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 α expression and glucokinase activity"
-
October
-
Wang, ZQ; Lu; Leng; Fang; Chen; Wang; Dong; Yan (October 2008). "Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 α expression and glucokinase activity". World journal of gastroenterology 14 (39): 6004-11.
-
(2008)
World journal of gastroenterology
, vol.14
, Issue.39
, pp. 6004-6011
-
-
Wang, Z.Q.1
Lu2
Leng3
Fang4
Chen5
Wang6
Dong7
Yan8
-
23
-
-
77949336458
-
"Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics"
-
May
-
Gu Y, Zhang Y, Shi X et al. (May 2010). "Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics". Talanta 81 (3): 766-72.
-
(2010)
Talanta
, vol.81
, Issue.3
, pp. 766-772
-
-
Gu, Y.1
Zhang, Y.2
Shi, X.3
-
24
-
-
84935098094
-
Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: The roles of long chain fatty acids
-
Aug 20
-
Hafizi Abu Bakar M, Kian Kai C, Wan Hassan WN, Sarmidi MR, Yaakob H, Zaman Huri H. Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids. Diabetes Metab Res Rev. 2014 Aug 20. doi: 10.1002/dmrr.2601.
-
(2014)
Diabetes Metab Res Rev
-
-
Hafizi Abu Bakar, M.1
Kian Kai, C.2
Wan Hassan, W.N.3
Sarmidi, M.R.4
Yaakob, H.5
Zaman Huri, H.6
-
25
-
-
85027931488
-
Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats
-
Jun
-
Chen W, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011 Jun;12(2):705-11
-
(2011)
AAPS PharmSciTech
, vol.12
, Issue.2
, pp. 705-711
-
-
Chen, W.1
-
26
-
-
0036797498
-
The involvement of P-glycoprotein in berberine absorption
-
Oct
-
Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol. 2002 Oct;91(4):193-7.
-
(2002)
Pharmacol Toxicol
, vol.91
, Issue.4
, pp. 193-197
-
-
Pan, G.Y.1
Wang, G.J.2
Liu, X.D.3
Fawcett, J.P.4
Xie, Y.Y.5
-
27
-
-
0036893418
-
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers
-
Dec
-
Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci. 2002 Dec;91(12):2614-21.
-
(2002)
J Pharm Sci
, vol.91
, Issue.12
, pp. 2614-2621
-
-
Maeng, H.J.1
Yoo, H.J.2
Kim, I.W.3
Song, I.S.4
Chung, S.J.5
Shim, C.K.6
-
28
-
-
0033980182
-
P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
-
Feb
-
Fromm MF. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther. 2000 Feb;38(2):69-74.
-
(2000)
Int J Clin Pharmacol Ther
, vol.38
, Issue.2
, pp. 69-74
-
-
Fromm, M.F.1
-
29
-
-
0242552872
-
Importance of P-glycoprotein for drug disposition in humans
-
Nov
-
Fromm MF. Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest. 2003 Nov;33 Suppl 2:6-9.
-
(2003)
Eur J Clin Invest
, vol.33
, pp. 6-9
-
-
Fromm, M.F.1
-
30
-
-
85027933072
-
Drug interactions and antiretroviral drug monitoring
-
Sep
-
Foy M, Sperati CJ, Lucas GM, Estrella MM. Drug interactions and antiretroviral drug monitoring. Curr HIV/AIDS Rep. 2014 Sep;11(3):212-22
-
(2014)
Curr HIV/AIDS Rep
, vol.11
, Issue.3
, pp. 212-222
-
-
Foy, M.1
Sperati, C.J.2
Lucas, G.M.3
Estrella, M.M.4
-
31
-
-
84896985226
-
Trends in drug delivery through tissue barriers containing tight junctions
-
Apr 1
-
Tscheik C, Blasig IE, Winkler L. Trends in drug delivery through tissue barriers containing tight junctions. Tissue Barriers. 2013 Apr 1;1(2):e24565
-
(2013)
Tissue Barriers
, vol.1
, Issue.2
-
-
Tscheik, C.1
Blasig, I.E.2
Winkler, L.3
-
32
-
-
67649118305
-
Tight junction modulator and drug delivery
-
May
-
Matsuhisa K, Kondoh M, Takahashi A, Yagi K. Tight junction modulator and drug delivery. Expert Opin Drug Deliv. 2009 May;6(5):509-15.
-
(2009)
Expert Opin Drug Deliv
, vol.6
, Issue.5
, pp. 509-515
-
-
Matsuhisa, K.1
Kondoh, M.2
Takahashi, A.3
Yagi, K.4
-
33
-
-
0035478758
-
Chitosan and its derivatives as intestinal absorption enhancers
-
Oct 1
-
Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S91-101.
-
(2001)
Adv Drug Deliv Rev
, vol.50
, pp. S91-S101
-
-
Thanou, M.1
Verhoef, J.C.2
Junginger, H.E.3
-
34
-
-
0035813752
-
Oral drug absorption enhancement by chitosan and its derivatives
-
Nov 5
-
Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001 Nov 5;52(2):117-26.
-
(2001)
Adv Drug Deliv Rev
, vol.52
, Issue.2
, pp. 117-126
-
-
Thanou, M.1
Verhoef, J.C.2
Junginger, H.E.3
-
35
-
-
43049096476
-
Chitosan-N-acetyl cysteine conjugates: In vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties
-
May
-
Schmitz T, Hombach J, Bernkop-Schnürch A. Chitosan-N-acetyl cysteine conjugates: in vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties. Drug Deliv. 2008 May;15(4):245-52.
-
(2008)
Drug Deliv
, vol.15
, Issue.4
, pp. 245-252
-
-
Schmitz, T.1
Hombach, J.2
Bernkop-Schnürch, A.3
-
36
-
-
33344454616
-
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine
-
Mar 10
-
Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release. 2006 Mar 10;111(1-2):41-6.
-
(2006)
J Control Release
, vol.111
, Issue.1-2
, pp. 41-46
-
-
Werle, M.1
Hoffer, M.2
-
37
-
-
63949085491
-
Trimethyl chitosan and its applications in drug delivery
-
May, Epub 2008 Dec 27
-
Mourya VK, Inamdar NN. Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med. 2009 May;20(5):1057-79. Epub 2008 Dec 27.
-
(2009)
J Mater Sci Mater Med
, vol.20
, Issue.5
, pp. 1057-1079
-
-
Mourya, V.K.1
Inamdar, N.N.2
-
38
-
-
3843146208
-
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs
-
Sep
-
Van der Merwe SM, Verhoef JC, Verheijden JH, Kotzé AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm. 2004 Sep;58(2):225-35.
-
(2004)
Eur J Pharm Biopharm
, vol.58
, Issue.2
, pp. 225-235
-
-
Van der Merwe, S.M.1
Verhoef, J.C.2
Verheijden, J.H.3
Kotzé, A.F.4
Junginger, H.E.5
-
39
-
-
0033007333
-
Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2)
-
Feb
-
Kotzé AF et al. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2). J Pharm Sci. 1999 Feb;88(2):253-7.
-
(1999)
J Pharm Sci
, vol.88
, Issue.2
, pp. 253-257
-
-
Kotzé, A.F.1
-
40
-
-
28444456377
-
Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant
-
Jan
-
Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm. 2006 Jan;62(1):52-8.
-
(2006)
Eur J Pharm Biopharm
, vol.62
, Issue.1
, pp. 52-58
-
-
Takatsuka, S.1
Kitazawa, T.2
Morita, T.3
Horikiri, Y.4
Yoshino, H.5
-
41
-
-
34248673162
-
Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant
-
Jun 29
-
Takatsuka S, Morita T, Horikiri Y, Yamahara H, Saji H. Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant. Int J Pharm. 2007 Jun 29;338(1-2):87-93.
-
(2007)
Int J Pharm
, vol.338
, Issue.1-2
, pp. 87-93
-
-
Takatsuka, S.1
Morita, T.2
Horikiri, Y.3
Yamahara, H.4
Saji, H.5
-
42
-
-
28744457833
-
Sublingual delivery of insulin: Effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity
-
Dec
-
Cui CY et al. Sublingual delivery of insulin: effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity. Biol Pharm Bull. 2005 Dec;28(12):2279-88.
-
(2005)
Biol Pharm Bull
, vol.28
, Issue.12
, pp. 2279-2288
-
-
Cui, C.Y.1
|